Status:
COMPLETED
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab
Lead Sponsor:
University of Sao Paulo
Conditions:
Macular Edema
Diabetic Retinopathy
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
Purpose: To evaluate the effects of anterior chamber paracentesis, brimonidine and oral acetazolamide to reduce intra-ocular pressure (IOP) variations after intravitreal bevacizumab injection (IVBV). ...
Eligibility Criteria
Inclusion
- macular edema
Exclusion
- pulmonary chronic problems
- chronic renal failure
- intraocular inflammation
- drug or alcohol addiction
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00804921
Last Update
December 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Medicine - Clinical Hospital
Ribeirão Preto, São Paulo, Brazil, 14049-900